Publications
5674 Results
- Journal / Conference
- Breast Cancer Research and Treatment 143(2):351-358;
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID24352574
- PMC
- PMC3889983
- Study Number(s)
- S0102
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102
- Journal / Conference
- Cancer Epidemiology, Biomarkers & Prevention 23(8):1638-1648;
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID25028457
- PMC
- PMC4119542
- Study Number(s)
- SWOG-9217
Factors Associated with Adherence to an End-of-study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217)
- Journal / Conference
- American Journal of Hematology 89(6):639-645;
- Year
- 2014
- Research Committee(s)
- Lymphoma
- PMID
- PMID24633940
- PMC
- PMC4137041
- Study Number(s)
- S0014, SWOG-8516 (INT-0067), SWOG-8736 (INT-0093), SWOG-9125, SWOG-9240, SWOG-9349, S9704
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma
- Journal / Conference
- British Journal of Haematology 28(2):245-250;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24383844
- PMC
- PMC4117470
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918
Unsuccessful cytogenetic analysis is a poor prognostic feature in acute myeloid leukemia
- Journal / Conference
- Journal of the National Cancer Institute 106(4):dju013;
- Year
- 2014
- Research Committee(s)
- Genitourinary
- PMID
- PMID24565955
- PMC
- PMC3982883
- Study Number(s)
- S0421
Serum biomarkers of bone metabolism in castration resistant prostate cancer patients with skeletal metastases
- Journal / Conference
- American Journal of Surgical Pathology 38(4):494-501;
- Year
- 2014
- Research Committee(s)
- Lymphoma
- PMID
- PMID24625415
- PMC
- PMC3955880
- Study Number(s)
- S9704
Clinical significance of MYC protein expression and/or high grade morphology in non-Burkitt, diffuse aggressive B-cell non-Hodgkin lymphomas: a SWOG S9704 correlative study
- Journal / Conference
- British Journal of Haematology 165(4):497-503;
- Year
- 2014
- Research Committee(s)
- Leukemia
- PMID
- PMID24528179
- PMC
- PMC4064464
- Study Number(s)
- S0521
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy
- Journal / Conference
- Blood 123(1):78-85;
- Year
- 2014
- Research Committee(s)
- Myeloma
- PMID
- PMID24144643
- PMC
- PMC3879908
- Study Number(s)
- S0120
Clinical, genomic and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).
- Journal / Conference
- Cancer 120(19):2980-2985
- Year
- 2014
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID25041791
- PMC
- PMC4284963
- Study Number(s)
- S0727
Dual blockade of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)
- Journal / Conference
- Journal of Clinical Oncology 32(23):2463-2470;
- Year
- 2014
- Research Committee(s)
- Lung
- PMID
- PMID25002722
- PMC
- PMC4121504
- Study Number(s)
- S0802